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Abstract 
We present a protocol for building, validating and simulating models of signal transduction networks. 
These networks are challenging modelling targets due to the combinatorial complexity and sparse 
data, which have made it a major challenge even to formalise the current knowledge. To address this, 
the community has developed methods to model biomolecular reaction networks based on site 
dynamics. The strength of this approach is that reactions and states can be defined at variable 
resolution, which makes it possible to adapt the model resolution to the empirical data. This improves 
both scalability and accuracy, making it possible to formalise large models of signal transduction 
networks. Here, we present a method to build and validate large models of signal transduction 
networks. The workflow is based on rxncon, the reaction-contingency language. In a five-step 
process, we create a mechanistic network model, convert it into an executable Boolean model, use the 
Boolean model to evaluate and improve the network, and finally export the rxncon model into a rule 
based format. We provide an introduction to the rxncon language and an annotated, step-by-step 
protocol for the workflow. Finally, we create a small model of the insulin signalling pathway to 
illustrate the protocol, together with some of the challenges - and some of their solutions - in 
modelling signal transduction. 
 
 
Keywords: Signal transduction, rxncon, network reconstruction, rule based modelling, Boolean 
modelling  
 
  
1. Introduction 
Here, we present rxncon, the reaction-contingency language, as a tool to develop rule based models. 
Rule based modelling has been established as a powerful approach to modelling signal transduction 
networks [1, 2]. The main strength of the rule based approach is the adaptive resolution: Rules define 
reactions at an arbitrary resolution, where some features of the reactants may be specified while other 
are left undefined [3]. This is particularly useful when modelling the notoriously complex signal 
transduction networks [4, 5]. These networks typically transfer information by covalent modification 
or complexation of components. A single component may have many such state variables, which 
combines combinatorially into a large number of possible specific configurations, or microstates [6]. 
In contrast, empirical measurements are typically at the level of elemental, or macroscopic, states, 
which are only defined for a single state variable and hence correspond to non-disjunct sets of 
microstates [7]. By representing the network in terms of non-disjunct sets of reactions and states, the 
rule based approach avoids enumerating all the possible microstates in the system. This gives two 
powerful advantages: In comparison to microstate based models, the rule based models scale more 
efficiently and more accurately represent the underlying empirical knowledge [8]. 
The rxncon language takes this even further by fully adapting the network definition to empirical data. 
The network definition is separated between elemental reactions, i.e. the biochemical transitions that 
change elemental states, and contingencies, i.e. the dependencies of these transitions on elemental 
states (Fig 1) [9]. The elemental reactions and contingencies correspond more closely to empirical 
data than microstate or even rule based models (discussed in [8]). However, the rxncon language is 
closely related to the rule based languages: A rxncon network model fully defines a rule based model, 
which can be compiled automatically in the BioNetGen language ([10]; in preparation). In addition, 
rxncon offers a number of advantages compared to working directly with the rules: First, the rxncon 
language more closely relates to empirical knowledge, making it easier to write and maintain a rxncon 
model. Second, it is supported by an iterative model building – validation – gap finding & gap filling 
workflow that helps developing and debugging the network model [11, 12]. Third, it supports 
automatic model visualisation in compact graphical formats [13]. Fourth, the rxncon network 
constitutes an annotated knowledge-base that is human and machine readable, and hence easily 
reusable for further model construction, merging or analysis [8]. However, the rxncon network must 
be compiled into an executable model before it can be simulated. 
In this chapter, we present a workflow to develop rule based models using rxncon. The core of the 
manual is a protocol covering five stages: (i) How to create a seed network that defines the model 
scope, (ii) how to turn the seed into a mechanistic rxncon network, (iii) how to convert the rxncon 
network into an executable Boolean model, (iv) how to use the Boolean model for qualitative network 
validation and debugging, and (v) how to export the final rxncon network into a rule based model. 
This protocol is based on the second generation rxncon and its improved expressiveness and model 
generation semantics ([9, 12]; in preparation). We briefly introduce the language with syntax and 
semantics, and highlight where the network definition and model generation differ from the first 
version. Finally, we illustrate the language and the workflow by using rxncon 2.0 to develop a rule 
based model of a small part of the insulin signalling pathway. 
 
1.1 The rxncon language 
The rxncon language defines biochemical reactions in terms of components, elemental states, 
elemental reactions and contingencies (Fig 1; [9]). The components are the independent agents in the 
network: The proteins, the second messengers, etc. They correspond to the molecules in rule based 
models. The elemental states are fully defined and indivisible state properties of one or more 
components, such as a specific covalent modification on a specific site, an interaction between two 
specified domains of two proteins, or the absence of any modification or interaction on a specific 
residue or domain, respectively. In terms of rule based models, an elemental state corresponds to the 
state at one specific site. The elemental states are the actual information carriers, as they define the 
mechanistic changes in the signalling network that transfer information. The elemental reactions are 
indivisible reaction events that produce or consume one or more elemental states (Table 1; Fig 2). 
Elemental reactions are defined as fully decontextualized skeleton rules [9], meaning that only the 
catalyst (if any) and the reaction centre are defined [14]. In other words, only the core components 
and the elemental states that change in the reaction are defined. Finally, the contingencies define the 
prerequisite states that are required for the reaction. In terms of rule based models, the contingencies 
correspond to the reaction context – i.e. the elemental states that are required for, but do not change 
through, the reaction. In rxncon, both elemental reactions and contingencies are defined in terms of 
elemental states. The contingency definition can be made arbitrarily complex by using Boolean 
combinations (AND, OR NOT) of elemental states, which can be used to define structured complexes 
when necessary. Hence, rxncon can be used to build a model that is as complex as necessary (as 
defined by empirical data), but not more complex. 
There are two strategies to simulate rxncon networks. First, the bipartite network definition can be 
compiled into a bipartite Boolean model that can be simulated without further parametrisation [12, 15, 
16]. In this case, elemental reactions and elemental states appear as distinct sets of nodes with two sets 
of update rules: The state node updates are determined by the elemental reactions, and the reaction 
nodes by contingencies. Based on a set of standard assumptions, each rxncon network defines a 
unique Boolean model with fully specified update rules. Below, we will use this to validate the 
network structure before generating a rule based model. Second, the reaction and contingency 
information can be compiled into a rule based model ([10]; in preparation). The elemental reactions 
provide the skeleton rules that define the reaction centre. The skeleton rules are refined by applying 
contingencies, which define the reaction context. The complete model creation process is 
implemented in the rxncon compiler. 
These two modelling strategies differ in detail and perspective: The rule base model creates reaction 
rules at the level of molecules, while the Boolean simulates the reaction network at the level of the 
system. Consequently, states that are mutually exclusive at the level of individual molecules may 
coexist in the Boolean model. In addition, the rule based model requires rate law assignments and 
parametrisation, in contrast to the bipartite Boolean model that can be simulated without quantitative 
information. Hence, the second can be used to validate and debug the network structure before the 
generation and parametrisation of a rule based model. 
This protocol below is based on rxncon 2.0, which is described in detail elsewhere ([9, 12]). We have 
updated the rxncon language to improve the expressiveness and model generation semantics. In 
particular, the rxncon now supports definition of structured complexes that can distinguish e.g. cis- 
and trans-phosphorylation across homodimers, which was not possible in rxncon 1.0 [10]. 
Furthermore, the reaction definition syntax has been refined and now explicitly includes neutral 
elemental states, such as unmodified residues and unbound binding domains (Fig 2; Table 1). 
Together with a flexible definition of elemental reactions through skeleton rules, these changes make 
it possible to define essentially any reaction rule at the level of biomolecular site dynamics using the 
rxncon language. 
However, there are certain limitations to rxncon. First, the rxncon network defines a qualitative 
network model (QlM;[8]). The network can indeed be converted into a ready-to-run rule based model, 
but this model has trivial parameters and initial conditions [12]. Quantitative information must be 
added directly in the rule based model code. Second, the rule based modelling languages can encode 
processes that are not possible to express in elemental reactions and contingencies, e.g. via functions 
in the BioNetGen language [3]. Finally, the rxncon language is reaction focused at the molecular 
level. It is difficult or impossible to meaningfully model higher level mechanisms, such as e.g. actin 
polymerisation or vesicle transport. Nevertheless, within the scope of biomolecular site dynamics, 
rxncon provides a powerful approach to model development. 
 
1.2 Developing a rule based model with rxncon 
Here, we present a detailed workflow for developing rule based models with rxncon. The workflow is 
inspired by the analogous workflow for metabolic network reconstruction [17], but uses methods that 
are tailored to the very different properties of signal transduction networks ([11]; reviewed in [8]). 
The workflow can be broken down into five steps: (i) Scope definition and network seed creation, (ii) 
refinement of the seed into a mechanistic QlM, (iii) conversion of the QlM into an executable bipartite 
Boolean model (bBM), (iv) evaluation of the bBM and hence the functionality of the QlM, and (v) 
conversion of the QlM into a rule based model. Steps (ii) – (iv) are typically performed iteratively, 
until the bBM reproduces the expected in vivo functions in silico. The objective of the workflow is to 
create a well annotated knowledge base, that qualitatively reproduces the system level function, and to 
convert this knowledge base into a rule based model. For clarity, we present this as a sequential 
workflow. However, this would in practice be an iterative process where the literature is used both to 
refine the scope and the mechanistic model simultaneously. 
The process starts with a biological question or topic of interest. The process is easier when this is the 
function of one or more pathways, as these have defined functions in terms of inputs (what does the 
process respond to or require?) and outputs (what does the process do?). Knowledge of inputs and 
outputs will help defining the scope, interpret the literature, and to validate the final model. In this 
case, we know which macroscopic input-output behaviour to expect, and can use this knowledge to 
evaluate the completeness and accuracy of the microscopic biochemical reaction network we defined. 
The rxncon language is also suitable for true bottom up model building: Elemental reactions are 
independent of other elemental reactions, and contingencies are independent of other contingencies. 
Hence, the language is highly composable, which greatly facilitates network reconstruction from 
fragmented information. However, the current strategy for validation relies on comparison to known 
macroscopic input/output behaviours. Therefore, we will assume that the model is built in the context 
of a pathway or process with defined inputs and outputs. 
Once the scope is defined in terms of inputs and outputs, it is helpful to collect information on which 
components are needed to convey the information from the input to the output. This information is 
typically available from genetic data, where studies have shown that certain signals or processes 
require certain components. These studies can also be used to derive epistatic information, i.e. in 
which order components act in the pathway, and this can be used to compose a draft network (Fig 1). 
The scope in terms of inputs/outputs and components can typically be collected from review papers. 
In practice, this is the reading up step of getting in to the topic, and the formal creation of a network 
seed is optional.  
The second step is to create the mechanistic model. To turn the network model into a mechanistic 
QlM, two layers of information are required (Fig 1): First, what are the actual biochemical transitions 
in the network? Second, what are the causal relationships between these transitions? Practically, the 
easiest is to start with pairs of components that are thought to be directly connected to each other and 
search for biochemical reactions that connect these components. To define the elemental reactions and 
states, three parts of information are needed; the components involved, the type of reaction between 
them, and the state the reactions result in. Typically, the state is observed and the reaction type needs 
to be inferred. To isolate indirect and direct effects, reactions should typically be monitored in vitro. 
The most reliable data for building the reaction layer is in vitro biochemical data. 
The causal layer is more elusive. The contingencies are defined as the effect of one or more elemental 
states on an elemental reaction. To infer causal effects of previous state modification, e.g. the role of 
phosphorylation in activation of a protein, more complex data is needed. Ideally, this information is 
based on a combination of genetic and biochemical in vitro experiments, where mutant forms of 
proteins are isolated and analysed. For example, candidate phosphorylation residues can be 
substituted to mimic or prevent phosphorylation, and the activity of the mutant protein compared to 
the wild type protein. While the states needed to infer the reaction layer can be measured in high-
throughput (although with the risk of scoring indirect effects), the information required for the 
contingency layer can to date only be generated with dedicated low throughput experiments. 
We recommend using primary literature to build the QlM. Review articles are excellent to define the 
scope and to create a network seed. They can also be used to build a mechanistic model, as we do in 
the example of the insulin pathway. However, the objective is a detailed mechanistic model, based on 
highly specific statements. This level of detail is often missing in review papers, or in the text in 
original papers, and we find it invaluable to return to the actual empirical data. In our experience, high 
quality curation often involves reinterpretation of the underlying experimental evidence. 
The output of the second step is a QlM in the rxncon language. It is defined as a table of elemental 
reactions, which defines the reaction layer, and a table of contingencies, which defines the causal 
layer together with the reactions. The model can be visually inspected at both levels of detail. The 
reaction layer can be visualised as a rxncon reaction graph (Fig 1B; Fig 3B). Each edge corresponds 
to a reaction, and a chain of reactions is required, but not sufficient, to allow information transfer. The 
full QlM can be visualised in the rxncon regulatory graph. This bipartite graph visualises elemental 
reactions and states as nodes connected by reaction and contingency edges. Paths from inputs to 
outputs are required, but again not sufficient, for information transfer (rRG; Fig 1D; Fig 4). It is only 
meaningful to proceed to model generation and evaluation if there are paths from the inputs to the 
outputs in the rRG. 
The third step is the model generation. In this step, the rxncon QlM is converted into a bBM based on 
the rRG network. This bipartite network has two node types; elemental reactions and elemental states, 
which follow two distinct update rules, as described in detail elsewhere [12]. The bBM is fully 
defined by the QlM, given a set of standard assumptions, and the model generation can be performed 
automatically. 
The fourth step is the model evaluation. In this step, the bBM is used to simulate the network in 
response to changing inputs, and the simulation results compared to the known in vivo behaviour. For 
each input/output pair, the process tests if the output is responsive to the input, and if the signal is 
transmitted by the pathway. If not, this discrepancy is used for targeted model improvement, and the 
process returns to step two or even one to extend or refine the QlM. If all tests of the bBM pass, the 
QlM is considered qualitatively functional and ready for conversion into a rule based model. 
The fifth step is to convert the QlM into a rule based model. The rxncon framework code can compile 
a set of rxncon statements into a rule-based model formulated in BNGL, as will be described in detail 
elsewhere (in preparation). Here, we will briefly touch upon several elements that constitute a rule-
based model and their relation to a rxncon model. 
To determine the Molecule Types, the elemental states appearing in the rxncon model are grouped by 
component. The modification states are then grouped by residue: these determine the molecule’s sites 
and their possible modifications. The interaction states’ domains are also mapped to molecular sites. 
The model is seeded by default with “neutral molecules”: this means that all modifications are in the 
neutral state and all molecules are unbound. 
Each elemental reaction, combined with its contingencies, is then translated into one or more rules. 
The reaction’s skeleton rule provides the rule’s centre, whereas every solution to its contingency’s 
Boolean equation provides a possible context for that rule. For example, a straightforward elemental 
state requirement will provide only one such context. On the other hand, a Boolean OR statement of 
three phosphorylation sites will lead to seven contexts due to combinatorics. To translate Boolean 
NOT statements, the complementary values at a molecular site are taken, connected via an OR. 
Finally, the output states in rxncon are mapped on BNGL observables. 
  
2. Material 
1. The rxncon framework 
The rxncon framework is distributed in two varieties: as a full framework, including a web-based 
front-end, and as a Python library for inclusion in an existing pipeline. Both varieties require a 
preinstalled Python (v3.5 or higher)1. The rxncon software is developed open source, and distributed 
under the lGPL license. The code is available from Github (https://github.com/rxncon/rxncon). 
Both the standalone Python 3 library and the graphical user interface can be installed from the Python 
Package Index (PyPI) via the pip tool2. All necessary dependencies are automatically resolved and 
installed. 
 
2. The rxncon input file: spreadsheet template 
The rxncon models are most easily defined in SBtab compatible spreadsheet files. A template can be 
downloaded from GitHub (template.xls; https://github.com/rxncon/models/). To work with this file, 
we recommend MS Excel or Gnumeric. 
To build a rxncon network, the user needs to fill two lists: The reaction and contingency lists, as 
described in detail in section 3 below. The reaction definition is supported by two additional sheets: 
the ReactionTypeDefinition, which lists all valid reaction types, and the ModificationTypeDefinition, 
which lists all valid modification types. Both these lists are extendable, enabling easy extension and 
customisation of the rxncon langague. 
In the reaction list, the elemental reactions are defined as two specs and a reaction type (see: [9] for 
details). Each spec corresponds to a component and possibly a domain and/or residue definition. Each 
Spec definition is separated into up to three columns, as exemplified by component A : 
!ComponentA:Name: Name of reaction partner A (the subject), e.g. a protein.  
!ComponentA:Domain (optional): Domain of reaction partner A. 
!ComponentA:Residue (optional): Residue of reaction partner A. 
The “!Reaction” column specifies the reaction type, which must refer to a unique reaction key in the 
ReactionTypeDefinition sheet (in column “!UID:ReactionKey”; see below). 
In addition, the network can be annotated through the following columns. Entries in those fields does 
not influence parsing or processing, but can be used to increase the quality and reusability of the 
model: 
!Quality: Quality of the empirical evidence of the reaction, e.g. the type of experiments or 
your confidence in the reaction assignment. 
!Literature:Identifiers:pubmed: Identification tag of source of information. We prefer using 
PubMed identifiers, but any unique identifiers can be used.   
!Comment: Comment the reaction if necessary. 
Note: It is advisable to clearly distinguish any hypothetical reactions added to debug the 
model from high confidence reactions based on empirical data to make sure the actual 
knowledge-base can be separated from pragmatic model improvements.  
The “!UID:Reaction” column is a concatenation of the information from the Component & Reaction 
columns into a unique reaction ID. It will be filled automatically by excel. Make sure to copy the 
functions from the rows above, but do not edit them. 
 
In the contingency list, the contingencies are defined in an object-verb-agent passive clause over the 
following columns: 
!Target: An elemental reaction or output that is regulated. The target column is also used to 
define Boolean states (see Fig 2). Outputs are defined as text strings within hard brackets, e.g. 
“[Output]”, Boolean states are defined as text strings within pointy brackets 
“<BooleanState>”, and elemental reactions are defined by the unique ID from the reaction list 
(in column “!UID:Reaction”). 
Tip: In spread sheet editors like Excel, it is convenient to link the cell to the reaction in the 
reaction sheet. This way, the contingency will be updated as soon as the reaction is updated. 
This is not necessary but makes the editing more convenient. 
!Contingency: The contingency required for the reaction in “!Target”. There are six valid 
contingency types: “!” Absolute requirement; “x” Absolute inhibition; “K+” Positive 
influence (increase of reaction rate); “K-“ Negative influence (decrease of reaction rate); “0” 
No effect; “?” No known effect. Boolean definitions take Boolean operators instead; “AND”, 
“OR” or “NOT”. 
!Modifier: The elemental state, Boolean state or input that the “!Target” depends on. Inputs 
are defined as text strings within hard brackets, e.g. “[Input]”, Boolean states are defined as 
text strings within pointy brackets “<BooleanState>”, and elemental states are defined by the 
elemental state string.3, 4 
As in the reaction list, there are three columns used for model annotation: “!Quality”, 
“!Reference:Identifiers:pubmed”, and “!Comment”. 
 
The ReactionTypeDefinition sheet holds all valid reaction types. Each reaction type needs a unique 
ID5 and is defined by a skeleton rule, a type and resolution definition of the components, and a type of 
directionality. 
 “!UID:Reaction “: Free text name of reaction. 
 “!UID:ReactionKey”: Unique identifier for the reaction type. 
 “!BidirectionalVerb”: Typically “no”, if  “yes”, reactions are generated in both directions. 
 “!MolType”: The type of molecule the reaction targets, e.g. Protein, mRNA, Gene or Any. 
 “!Resolution”: The locus resolution needed: Component, Domain or Residue. 
 “!SkeletonRule”: Semantic definition of the reaction type. 
To create new reaction types, it suffices to add a new entry to the list as long as the modification type 
is declared in the ModificationTypeDefinition sheet. If not, the new modification type must be added 
to this list: Make sure the ID is unique and that the type and resolution definitions are consistent with 
the skeleton rule. For more details, see [9]. 
 
3. Model visualisation: Cytoscape 
The visualisation of rxncon networks will use Cytoscape, which can be downloaded from 
cytoscape.org. The graphical styles used for the reaction and regulatory graphs can be downloaded 
from GitHub (rxncon2cytoscape.xml; https://github.com/rxncon/tools). 
 
4. Bipartite Boolean simulation: BoolNet & R 
The logical simulation of rxncon networks uses BoolNet, an R package. 6 To use these tools: 
i. (Optional) Download and install R-studio (https://www.rstudio.com).7 
ii. Make sure you have R installed.8 
iii. Install the BoolNet package.9 
We have prepared an R-script for the simulation (“BoolNetSim.R”) which can be downloaded from: 
https://github.com/rxncon/tools. 
 
5. Agent based simulation: NFSim & BioNetGen 
The rule-based models generated by the rxncon framework require either BioNetGen or NFSim to 
simulate. We recommend NFSim, which contains BioNetGen but also supports agent based 
simulation, which will be necessary for larger networks. NFSim can be downloaded from 
http://michaelsneddon.net/nfsim/download/.10 
 
  
3. Method 
I. Define the model scope and create a network seed.11  
1. Define the activator (input) of the pathway and the expected behaviour (the output).12 
2. Define the components that connect the input(s) with the output(s). This information 
is typically available from review papers or paper introductions. 
3. Define the sequential order in which the components act, as far as possible. This is a 
refinement of (2), which helps to narrow down the search for mechanistic 
connections. If possible, determine which components are directly connected. 
4. Optional: Create a conceptual network in which you sketch important events of your 
pathway. These events can correspond to phenomenological observations and thus do 
not need to be on a molecular level. A conceptual network might help alongside to 
keep an overview. 
Exempli Gratia: The insulin signalling pathway – part 1. Our aim is to build a rule based model of 
the initial events in the insulin signalling pathway. Naturally, we chose insulin as the input. Choosing 
the outputs is less obvious, but we decide that we are interested in the initial signalling events. We 
hence chose the activation of the phosphoinositide 3-kinase (PI3K) and of Ras. We base these choices 
(and, for simplicity, all further work in this example13) on a single review paper [20]. Now, we 
identify the important components that connect the input with the output: The insulin receptor (IR) in 
its homodimeric form (the insulin receptor can also heterodimerise, but we leave this out); the insulin 
receptor substrate (IRS; again multiple forms exist), the Shc protein; the growth factor receptor-bound 
protein 2 (Grb2); the son of sevenless homolog (SOS); and the PI3K. We added phospholipids to 
model plasma membrane binding of some of the components. Finally, we sort the components in 
order and include the direct connections we gathered from the review. The scope and seed are 
summarised in figure 3A. 
II. Creation of a mechanistic model 
The mechanistic model is built in two layers: The reaction list defines the possible events in the 
network as decontextualised reactions between pairs of components (or intramolecular events in a 
single component), while the contingency list defines the contextual constraints on these reactions. 
The example model built here as well as a template is available for download from 
https://github.com/rxncon/models/. 
Definition of the reaction layer 
The reaction layer specifies which elemental states are produced or consumed by the interacting 
components.  It is built in the reaction list of the spreadsheet template (see material section above). 
1. For each presumed component pair, search the literature for reactions that 
connect the pairs.14 
2. Determine which reaction type best describes the event 15 (see the 
ReactionTypeDefinition sheet).  If no reaction type matches the event, define a 
new reaction type.16 
3. Enter the reaction type in the column “!Reaction”. 17 
4. Specify the component(s) taking part in the reaction. 18, 19 
- The name of the components should be specified in columns 
"!ComponentA:Name " and "!ComponentB:Name".20 
- (Optional) The name of the interaction domains should be specified in 
"!ComponentA:Domain" and "!ComponentB:Domain". 21, 22 
- (Optional) The name of the target residues should be specified in 
"!ComponentA:Residue" and "!ComponentB:Residue". 23 
5. Annotate the reaction entry 
- Optional: Use the column "!Quality" to specify the type of experiment and/or 
your confidence in the evidence. 
- Optional: Use the column "!Literature:Identifiers:pubmed" to annotate the 
source.24 
- Optional: Add comment in "!Comments" if desired. 
6. Repeat these steps until all the reactions you found are considered in the reaction 
list. It is often necessary to extend the search beyond the initial scope. 
 
The rxncon model is processed by the rxncon compiler, which can be accessed either from the 
command line or through a graphical user interface (in preparation). To use these rxncon compiler 
through the graphical user interface: 
7. Create a new project: 
„New“-Button on left sidebar and choose source: 
a. „ spreadsheet file“ 
i. Set the project name. 
ii. Click on ‘choose file’.  
iii. (Optional) Add a comment for this project in the project comment box. 
iv. Press „Upload File“.25 
b. „ Text input“ 
i. Set the project name. 
ii. Enter Quick input. 
iii. (Optional) Provide a comment. 
iv. Press „Save“. 
8. Update a project (spreadsheet input only): 
a. Click on the plus symbol of the respective project in the project sidebar. 
b. Choose your file, enter a comment if applicable, and click update. 
9. Load a project (activate it): 
a. Load the desired network to the workspace by clicking ‘load file’ (the bolt 
symbol).  
b. Load an older version of a project by first opening the detail view (the eye 
symbol), then push the load button of the respective version. 
 
Check for gaps in the reaction layer 
Next, we visualise the reaction layer with the rxncon reaction graph. This graph visualises all 
components, with domains and residues, as nodes and all reactions as edges. Information can only 
pass from one component to another if there is a path of reactions connecting the two. 
To visualise the reaction topology of the network: 
10. Create the reaction graph either from the command line or through the graphical 
user interface. 
a. To create the graph from the command line: 
Call the “rxncon2reactiongraph” script with the excel file as argument.26 
b. To create the graph through the GUI: 
i. Load the project. 
ii. In the top navigation bar, choose „Visualisation“ → „Reaction Graph“. 
iii. (Optional) Provide a comment. 
iv. (Optional) Reuse previous layout. 
To do this, import an .xgmml file with layout information. 27 
v. Create the graph by clicking “Create Graph”. 
vi. Retrieve the file by clicking the “Show” button in the respective detail view 
(the eye symbol).  
10. Load the .xgmml file in Cytoscape (>v3.4.0)  
11. Import the visual style file for rxncon.28 
12. Set the visual style to rxncon reaction graph. 
13. Move the nodes to retrieve an appealing network layout. 
Note: The domains and residues are intended to be laid out adjacent to the 
component node. This does not work well with automatic layouts.29 
14. Inspect the connectivity between the components. 
The objective is to determine if there is a mechanistic (reaction) path from each 
input to each output that responds to that input. To determine this, look for 
connections from the most upstream to the most downstream component in each 
information path (input-output path). The inputs and outputs will not be 
connected yet, as these connections are defined as contingencies (see below; Fig 
1B). 
15. If the network is not connected, extend the network with further reactions by 
either gathering additional empirical information or stating hypothetical reactions 
until you obtain a connected graph. 
16. Only proceed if there is a path from the most upstream to the most downstream 
components. 30 
 
Exempli Gratia: The insulin signalling pathway – part 2. Using the review [20], we identify the 
elemental reactions that connect the components with each other. We are searching for references to 
direct mechanistic connections, like “Interactions of insulin with IR have been studied in greatest 
detail …”, which we interpret as a direct binding of insulin to the insulin receptor (IR). In the reaction 
list of the rxncon sheet, we put IR as "ComponentA[Name]", the reaction type "i" for interaction and 
insulin as "ComponentB[Name]". To make the reactions and states elemental, we want to assign a 
domain name to each of the component. As we found no information on where insulin binds the IR, 
we called the domain on IR "lig" (for ligand) and entered it as "ComponentA[Domain]". Next, we 
find the information: “Shc proteins are … substrates of the IR and IGFR…” which identifies the 
phosphorylation of Shc by IR. We enter "IR" as "ComponentA[Name]", the abbreviation "P+" for 
phosphorylation as the reaction type and "Shc" as "ComponentB[Name]". In this case, the review 
mentions two distinct target residues the amino acid Y317 and YY239 (Y239, Y240 or both, which is 
not clear from the text; we refer to this site as YY239) that are phosphorylated: “All three Shc 
isoforms are tyrosine phosphorylated … on two distinct sites (YY239/240 and Y317).” Hence, we 
need two distinct reactions that differ only in their target residues. In the case of IRS, the review is 
less specific and refers only to tyrosine phosphorylation. Without further information, we enter this as 
a single site but suspect the review refers to multiple such sites that may have overlapping functions. 
We also find out that these residues form the core of binding domains, so we assign domain names 
(bd, bd1 or bd2 for “binding-domain”, as the review doesn’t specify domain names). We proceed 
through the review to build the reaction list presented in table 2. Once we consider the reaction list 
complete, we proceed to visualise it. To this end, we create a reaction graph of the network and check 
if we connected insulin (our most upstream component, as there is no input outside the model in this 
case) to the most downstream components; PI3K and SOS. The graph is connected (Fig 3B), and we 
proceed to the causal layer. 
 
Contingency definition 
The contingencies specify which (combinations of) elemental states have a regulatory effect on which 
reactions. 
17. Use primary literature to find contextual information.31 For each elemental 
reaction, define which (combination of) elemental state(s) of components A and 
B the reaction depends on.  
a. In the literature, look for data that identifies the active form of the 
components32. 
b. Define the active form in terms of an elemental state or a Boolean 
combination of several elemental states, e.g. modification(s) and bonds to 
other components.33 
c. Determine which part of the requirement is already defined in the 
reaction (e.g. components, source states). This should not be defined as 
contingencies. 
18. Define the contingencies in the "contingency list" in the rxncon template: 
a. Add the reaction that requires a contingency to the column "target". 
b. Define the type of contingency in column "Contingency".34 
c. In "Modifier", place the elemental state, Boolean state or input that 
regulates the reaction. Each reaction can use as many contingencies as 
needed. For combinations of contingencies, Boolean states (identified by 
pointy brackets < >) can be used to code complex requirements.35 The 
inputs (identified by hard brackets [ ]) define the regulation of the system 
by external factors. 36 
d. Add structure indexes if necessary. Under some circumstances, 
component names are not sufficient to define contingencies. In particular, 
this is the case when the component name is not unique, i.e. in case of 
complexes containing more than one subunit of the same kind.37 In these 
cases, a position label must be added to the contingencies (Figure 2). 
19. When Boolean states are used as modifiers, the Boolean state must be defined in 
the contingency list. To do this: 
a. Enter the Boolean state name (marked by pointy brackets: < >) in the 
target column. 
b. Enter the Boolean operator in the contingency column. Valid operators 
are AND, OR and NOT. 
c. Enter either an elemental state, another Boolean state, or an input as 
modifier. 
d. In structured complexes, define equivalences when necessary. 38 
20. Define the contingencies for the output of the network. In the context of rule 
definitions, the outputs will define the observables. 
a. Enter the output name (marked by hard brackets [ ]) in the target column. 
b. Enter the contingency as for elemental reactions above. 
c. Enter the modifiers as for elemental reactions above. 
 
Visualise the regulatory structure and check for gaps 
21. Create a regulatory graph. The process is analogous to the creation of the reaction 
graph (see (7) above). 39, 40 
22. Visualise the graph in Cytoscape. 41 
23. Inspect the graph: 
Determine if there is a directed path from each input to each output. 
If the network is not connected, extend the network with further reactions and/or 
contingencies by either gathering additional empirical information or stating 
hypothetical reactions until you obtain a connected graph and repeat the steps in 
this section. 
24. Only proceed to model generation if there is a path from each input to each 
output. 
 
Exempli Gratia: The insulin signalling pathway – part 3. To add the causal layer, we return to the 
literature (review) and search for information on how reactions are regulated. For example, we learn 
that Grb2 binds Shc when Shc is phosphorylated on residue(s) YY239. The SH2 domain in Grb2 
binds the phosphotyrosine at position 239/240 in Shc. We have already defined the reaction that Grb2, 
via its SH2 domain, binds Shc at the bd2 domain, which contains the YY239 residue. However, this 
residue must be phosphorylated. Consequently, we specify a contingency of the protein-protein 
interaction on the phosphorylation: the contingency sheet, we put the ppi-reactions between Grb2 and 
Shc in the "Target" column. To specify phosphorylation of this residue as a requirement, we put the 
state "Shc_[bd2(YY239)]-{P}" in the "Modifier" column and enter absolute requirement ("!") in the 
"Contingency" column. Based on the review paper, we cannot identify further contextual constraints 
on these bonds, though further requirements might appear if more literature is considered or new 
empirical data becomes available. Insulin binding is more difficult to define. Insulin binding requires 
receptor dimerisation, but only one insulin molecule can bind the receptor. In rxncon, we cannot 
define an interaction with a complex, so the reaction is “IR_[lig]_i_insulin” (IR interacts with 
insulin). Adding the requirement for dimerisation would be easy (IR_[lig]_i_insulin ! IR--IR), but we 
need a more complex statement to account for the fact that the dimer only binds a single insulin 
molecule. In the end, we settle for a Boolean state: <IR-empty> = IR@0--IR@1 AND IR@1_[lig]--0 
(see Figure 2). Here we make use of structured complexes, where the identity of each subunit is 
labelled by an “@” followed by a unique number. The reactants have index 0 (IR) and 1 (insulin), and 
we define in the contingency that the IR in the reaction is equivalent to the IR at position 0 in the 
Boolean state “<IR-empty>#IR@0=IR@0” (each Boolean has its own name space, see [9] for more 
details). Finally, as an example of an output contingency, we define the requirements for Ras 
activation. It is one of two possible outputs of the network. From the review, we gather that at least 
one of two conditions must be fulfilled: 1) Grb2 must be bound to IRS and SOS; 2) Grb2 must be 
bound to SOS and Shc. In this situation, it is convenient to use nested Boolean expressions to describe 
these conditions in the contingency list. First, we define with an OR statement that either complex 1) 
or 2) is needed. Next, we define the two Grb2 complexes. Based on the review, we continue to define 
contingencies until we consider the list complete (table 3; the complete model can be found in Sup 
File 1). At this stage, we visualise the reaction-contingency network in the regulatory graph (Fig 4). 
The objective is to determine if every input is connected to every output. In this model, we did not 
define an external input, instead using the neutral state of insulin (the binding reaction between IR and 
insulin is our most upstream node in the regulatory graph). Consequently, we check if there is a 
directed path from this node to each of the two outputs. This is the case and we proceed to the next 
step.  
 
III. Bipartite Boolean Model (bBM) generation and simulation 
The next step is to create an executable model from the QlM by exporting the rxncon network to a 
bipartite Boolean Model (bBM). The model generation uses an algorithm described in detail 
elsewhere [12].42 
1. Create the bipartite Boolean Model file. This can be done via the GUI or from the 
command line. 
a. To generate the model from the command line: 
Call the “rxncon2boolnet” script. 43 
Note: The model can be generated with different options. 44  
b. To generate the model from the GUI: 
i. Load the respective project. 
ii. In the top navigation bar, choose “Model Export” → “Boolean Model”. 
iii. (Optional) Provide a comment. 
iv. (Optional) Change default export parameters. 
Note: The model can be generated with different options. 45  
v. Create the BoolNet files by clicking “Create model files”. 
vi. Retrieve the files by clicking the “Show” buttons in the respective detail 
view (the eye symbol).  
 
The model creation generates three different files: 
- [model].boolnet:  The model file, encoded as symbolic update rules 
- [model]_symbols.csv: The key to the symbols in the model file 
- [model]_initial_vals.csv The initial state of the network 
where “[model]” is the file name (without extension) of your rxncon model. 
 
2. Inspect and/or adjust initial conditions. 46 
3. Simulate the file in BoolNet using RStudio: 47 
a. Save the network files and the R script into a single directory. 
b. Start RStudio. 
c. Open a new project and create it in the directory where you saved your files. 
d. Make sure your model files are located in the project folder. 48 
e. Open the R script. Set the filePrefix in the R script to [model]. 49 
f. Execute the entire script by selecting all text (ctrl+a) and pressing ctrl+enter. 
The script generates five files: 
1. [model].pdf   The simulation trajectory, graphical 
2. [model]_trajectory_first.csv The simulation trajectory, values 
3. [model]_2.pdf   Second simulation trajectory50, graphical 
4. [model]_trajectory_second.csv Second simulation trajectory, values 
5. [model]_new_attractor.csv The attractor reached51 
where “[model]” is the file name (without extension) of your rxncon model. 
4. Inspect the simulation results: [model].pdf; [model]_2.pdf. The first file displays the 
path to the attractor, the second the type of attractor (point = 2 columns; cyclic > 2 
columns). 
5. Save the file under new names before rerunning the script. The files will be 
overwritten. 
6. To repeat the simulation from the new steady state, rename the 
“[model]_new_attractor.csv” file “[model]_initial_vals.csv. 
7. (Optional) Adapt the input states to perturb the model. 
8. Repeat from (2) above. 
 
Exempli Gratia: The insulin signalling pathway – part 4. We export to a bBM using the rxncon 
framework (Sup. File 2-4). The model generation creates three files containing the model, the initial 
values, and a key between model IDs and the reaction and state names. The initial values file is 
already set to the default initial conditions: All neutral states are true (1). All other states, all reactions 
and all inputs are false (0). As we would like to use insulin as an input, we also set the neutral state of 
insulin to false (0). This default starting point allows the system to reach steady state in the absence of 
the signal, and we can then see how it reacts to the perturbation. We simulate the network to steady 
state and save the steady state, and as expected the output signals [PI3K] and [RAS] remains off. In 
the second round of the simulation process we set the neutral state of insulin (insulin_[IR]--0) to true 
(1). At the end of this simulation, the output signals [PI3K] and [RAS] are true. In round three, we 
turn insulin off again and expected to get the same attractor as in round one, but the outputs remain 
on. As we do not reach a steady state we have seen before, we proceed to a fourth round of 
simulation. We change insulin back to True and, as expected, the outputs are still on. As both the 
inputs and outputs are the same in steady state 2 and 4 (this was not the case for any previous pair of 
steady states), we proceed to compare the attractors. They are identical, and we proceed to the 
evaluation step, eager to figure out why the network cannot turn off after the initial activation. 
 
IV. Model validation and improvement 
The aim of the model validation is to identify which input-output pairs are connected by a functional 
information transfer path. To this end, we will turn inputs on and off and examine which outputs 
respond to these changes. 
1. Create the bipartite Boolean model and run the first simulation without editing the 
“[model]_intitial_vals.csv” file. 
2. Remove or rename the old initial_vals file, and replace it with the 
“[model]_new_attractor.csv” file by renaming it “[model]_initial_vals.csv”. Turn the 
input of interest on by setting the value to True (= 1). 52 
3. Move or rename previous output files to save them from being overwritten. 
4. Rerun the simulation and determine which output changes. 
5. Remove or rename the old initial_vals file, and replace it with the 
“[model]_new_attractor.csv” file by renaming it “[model]_initial_vals.csv”. Turn the 
input of interest off again by setting the value to False (= 0). 
6. Move or rename previous output files to save them from being overwritten. 
7. Rerun the simulation and determine which output changes. Compare the steady state 
to that after the first simulation (1). If the steady states are the same53, we are done 
with this particular input. If not, continue. 
8. Remove or rename the old initial_vals file, and replace it with the 
“[model]_new_attractor.csv” file by renaming it “[model]_initial_vals.csv”. Turn the 
input of interest on by setting the value to True (= 1). 
9. Move or rename previous output files to save them from being overwritten. 
10. Rerun the simulation and determine which output changes. Compare the steady state 
to that after the second simulation (4). If the steady states are the same, we are done 
with this particular input. If not, continue simulating with iterative input states until 
the attractor reached has been seen before. 
11. Evaluate the response of the effect of the input across all outputs and simulations, to 
determine which outputs are regulated by this input (according to the model). 54 
12. Compare to the known macroscopic input-output behaviour of the network. Is it 
reproduced by the network model? 
a. If yes: the model is considered functional – proceed to generate the rule based 
model. 
b. If not: use the simulation results to identify where the signal is blocked. If often 
helps to work from both directions: 55 
- How far does the signal reach from the input?  
- Which reactions/states should have responded in order to affect the output? 
13. Use the insight from the model analysis to improve the mechanistic model (Phase II). 
To debug the model: 
a. Search for the most upstream reaction or state node that does not respond. For 
most models, this is most easily done by sorting the heatmap on transitions and 
inspecting it visually (see Fig 5). 
b. If the most upstream node is a state, a reaction is either missing or off. 56 
c. Check if a valid reaction is included in the network, but blocked by 
contingencies. If so, re-examine these contingencies. 
d. If not, add a reaction targeting that state. Use this candidate reaction for a targeted 
literature search. If nothing can be found, consider experimental validation or 
enter it as a hypothetical reaction that needs to be verified. 
e. If the most upstream node is a reaction, there is a problem with the contingencies. 
Re-examine the contingencies to see how to make the reaction responsive in both 
directions – use the new contingencies for targeted literature search, experimental 
validation or to enter hypothetical mechanisms that need experimental 
verification as for reactions above. 
14. Repeat model generation and analysis. 
15. Analyse the new attractors; repeat QlM update – model generation – model 
evaluation until the bBM is functional.57 
16. Iterate until all input-output paths work as expected. 
17. In case the QlM model appears to be correct or complete, but the bBM fails to predict 
the expected input/output behaviour, consider if the bBM export assumptions are 
appropriate for this particular state or reaction (manually inspect the bBM to 
determine if there is any reason to redefine that particular update rule). 58 
18. To create a complete file of the simulation results, merge the 
“[model]_trajectory_first_simulation.csv” files into a single table. Most spread sheet 
programs can format cells depending on values to generate heat maps such as Figure 
5. 
 
Exempli Gratia: The insulin signalling pathway – part 5. Our initial model of the insulin pathway 
turned on but not off. To find out why the signal is interrupted in one direction, we inspect the 
simulation results in more detail. First, we visualise the simulation results in a heatmap, where states 
are sorted in order of activation (Fig 5A). We are particularly interested in the difference between 
steady state 1 (where insulin and outputs are off) and steady state 3 (where insulin is off and output 
should be off but are on) (Fig 5B). We extract the states and reactions that differ at these two steady 
states and visualise them in a separate panel (Fig 5C). We can see that in the attractor of round one, all 
of the phosphorylation states and reactions as well as the reactions depending on those states are OFF. 
In the attractor of round three these states and reactions are all ON including the output signal [PI3K] 
and [RAS]. This is interesting, because in round one we simulated the model without the input signal 
insulin and saw that the output signal does not change, but in round two we simulated with insulin ON 
and could observe an output response to the input signal, which does not turn OFF again after 
switching the input signal OFF again. If we have a closer look into the list of states and reactions that 
are different, we see that all the phosphorylated states and reactions depending on these states are OFF 
in the first round but ON in the third round. This indicates that the de-phosphorylation reactions 
required to antagonise the signal are missing. When we added hypothetical de-phosphorylation 
reactions to our system (table 4), the problem was resolved (Fig 5D & E): The attractor of round one 
and round three are the same, and the phosphorylated states as well as the downstream states and 
reactions turn off when insulin is removed. As the model now reproduces – qualitatively – the 
expected in vivo behaviour, we can proceed to the final step: generating the rule based model. 
 
V. Creation and simulation of the rule-based model 
1. Generate the rule based model.  
a. To create the rule based model from the command line: 
Call the “rxncon2bngl” script. 59  
b. To create the rule based model through the GUI: 
i. Load the respective project. 
ii. In the top navigation bar choose „Model Export“ → „Rule Based Model“. 
iii. (Optional) Provide a comment. 
iv. Create the BNGL file by clicking “Create model”. 
v. Retrieve the file by clicking the „Show“ button in the respective detail view 
(the eye symbol). 
2. This is model generation itself is automated, but the resulting model has trivial 
parameters (all = 1) and initial amounts (all = 1000). 
To simulate the model run the “BNG2.pl” Perl script with the generated BNGL file as 
input. By default, it is assumed that the network-free simulator NFsim is used. To use 
BioNetGen’s standard ODE simulation, the statement “simulate_nf” has to be 
changed to “simulate_ode”. For further details we refer to the BioNetGen 
documentation. 
Note: For simple systems, ODE simulations will give the best result. However, they 
require the full network (i.e. all the microstates that can be reached by applying the 
rules, starting from the initial states) to be generated. 
 
Exempli Gratia: The insulin signalling pathway – part 6; creation of the rule based model. We 
translated the rxncon model of the insulin pathway into a rule based model in the BioNetGen 
language. The model is available as an electronic supplement (Sup file 5). 
Components in the I-R model: In the insulin-receptor model there are eight different components. In 
our NFSim simulations we could easily handle 1000 copies of each component: simulating 150 units 
of time took only a couple of second on a modest mid-2013 laptop. However, even in this modest 
system, we have 27 rate constants (excluding the seven dephosphorylation reactions we add later), of 
which we typically have no precise value. 
Residues and domains: The elemental states are grouped by component name (i.e. “IR”) and within 
the component name by locus (residue or domain). Take for example the following elemental reaction 
in the insulin-receptor system: “IR_p+_IR_[TK(Y1158)]”, which consumes the state 
“IR_[TK(Y1158)]-{0}” and produces the state ”IR_[TK(Y1158)]-{p}”. These two states describe a 
property of the same residue, and will be translated to different internal states living on a single site of 
the IR molecule in BNGL. All in all, the Molecule Type declaration for the insulin receptor molecule 
looks as follows: 
“IR(IRBDD,JMD,JMDY972R~0~p,TKDY1158R~0~p,TKDY1162R~0~p,TKDY1163R~0~p,ligD)” 
In rxncon, modifications always happen at the residue level and bindings at the domain level. 
Therefore, if ambiguity arises due to a name clash, “R” or “D” is appended to the BNGL site name. 
Fully neutral forms: The fully neutral form, as it appears for the insulin receptor molecule is: 
“IR(IRBDD,JMD,JMDY972R~0,TKDY1158R~0,TKDY1162R~0,TKDY1163R~0,ligD)” We can 
identify empty IR, ligand and JM binding domains, and unphosphorylated Y1158, Y1162, Y1163 and 
Y972 residues. 
The output signals in the insulin-receptor model are PI3Kand the Ras signals. The first is a single 
bound state between IRS and PI3K, but the second is more interesting. The Ras signal has two 
contributions: the Shc--Grb2--SOS complex and the IRS--Grb2--SOS complex. These correspond to 
two different patterns. Since BNGL does not allow algebraic expressions in the Observables section, 
this is solved by appending numbers to the two contributions: 
Molecules PI3K0 IRS(bdD!1).PI3K(SH2D!1) 
Molecules RAS0 Grb2(SH2D!1,SOSD!2).SOS(Grb2D!2).Shc(bd2D!1) 
Molecules RAS1 Grb2(SH2D!1,SOSD!2).IRS(bdD!1).SOS(Grb2D!2) 
Contingencies containing explicit OR-statements or implicit ones (such as above) require some 
attention because of the “don’t write, don’t tell” principle of BNGL. Say that a reaction requires a 
phosphorylation at site 1 or site 2. If the reaction context of the first rule derived from this reaction 
has the phosphorylation at site 1, the context of the second rule (where site 2 is phosphorylated) 
should state explicitly that site 1 is unphosphorylated. We developed a procedure, closely related to 
the Gram-Schmidt orthogonalisation procedure, to make sure that all rules derived from an elemental 
reaction have disjunct contexts (in preparation). The rules generated by the rxncon framework 
automatically all have disjunct reaction contexts. 
 Simulation of the rule based model. Parametrisation and simulation of rule based models fall outside 
the scope of this chapter, but since we are interested in the response of our system to insulin, we will 
simulate the following, as explaned in detail in the text below: 
1. First, we will let the system run for 50 units of time without any insulin present, 
2. Then, suddenly, 1000 units of insulin are added to the system. We simulate for another 50 
units of time, 
3. After that we remove all the insulin and simulate for 50 units of time again. 
 
Exempli Gratia: The insulin signalling pathway – part 7; simulation of the rule based model. 
Studying the Boolean model led to the conclusion that we require extra dephosphorylation reactions 
to make sure the output signals turn off again when the insulin goes away. However, let us first try to 
study the response to 1-3 without these dephosphorylation reactions, to see how this works out in the 
rule-based model. 
BioNetGen has a setConcentration command that can adjust species concentrations mid-simulation, 
however the complete state of such a species has to be specified. For our step 2, the adding of insulin, 
this is convenient. For step 3, the removal, we will add a degradation rule for insulin controlled by a 
rate ins_deg_0 whose initial value is 0 and which will be changed to 100 through the setParameter 
command. The large value of this parameter, compared to the other rate constants, should make sure 
the insulin disappears almost instantaneously. 
The BNG actions at the end of the BNGL file for this setup are: 
generate_network({overwrite=>1}); 
simulate_ode({suffix=>"ode_before",t_end=>50,n_steps=>200}); 
setConcentration("insulin(IRD)", "1000"); 
simulate_ode({suffix=>"ode_during",t_end=>50,n_steps=>200}); 
setParameter("ins_deg_0", "100"); 
simulate_ode({suffix=>"ode_after",t_end=>50,n_steps=>200}); 
 After 14 iterations of applying the rules, 2587 species got created and 30839 reactions between them. 
The network generation took a handful of minutes on a modest laptop. Integrating the ODE system 
took roughly fifteen minutes. 
In Figure 6A, we can see the result of the simulation. Just as in the Boolean system (Fig 5A), the 
outputs do not switch off after removing the insulin. 
 Exempli Gratia: The insulin signalling pathway – part 8; the combinatorial complexity.  
The rule-based simulation plotted in Figure 6 shows the same behaviour as the Boolean simulation in 
Figure 5: after removal of the insulin, the output signal “stays stuck” in the ON state. We therefore 
add the same 7 dephosphorylation reactions to the rule-based model. When we try to run the ODE 
simulation again, this happens: 
BioNetGen version 2.2.6 
Reading from file insulin_dephos.bngl (level 0) 
Read 17 parameters. 
Read 15 molecule types. 
Read 15 species. 
Read 4 observable(s). 
Read 49 reaction rule(s). 
ACTION: generate_network( insulin_dephos ) 
Iteration   0:    15 species      0 rxns  0.00e+00 CPU s 
Iteration   1:    18 species      4 rxns  2.00e-02 CPU s 
Iteration   2:    19 species      8 rxns  0.00e+00 CPU s 
Iteration   3:    26 species     17 rxns  2.00e-02 CPU s 
Iteration   4:    51 species     75 rxns  7.00e-02 CPU s 
Iteration   5:    95 species    273 rxns  2.40e-01 CPU s 
Iteration   6:   148 species    665 rxns  5.20e-01 CPU s 
Iteration   7:   189 species   1145 rxns  6.10e-01 CPU s 
Iteration   8:   290 species   1611 rxns  5.50e-01 CPU s 
Iteration   9:   694 species   3019 rxns  1.80e+00 CPU s 
Iteration  10:  2889 species  10143 rxns  1.00e+01 CPU s 
Iteration  11: 19914 species  61810 rxns  8.56e+01 CPU s 
Iteration  12: 125172 species 492015 rxns  9.06e+02 CPU s 
After this, we stopped the network generation and reached for NFSim, the network-free simulator. 
Note how many more species get created by just adding these extra dephosphorylation reactions. 
 
Exempli Gratia: The insulin signalling pathway – part 9; network free simulation. 
Sadly, the setConcentration command does not work in NFSim. We have found a workaround, which 
we present here since we could not find it in the NFSim documentation or online. The problem is that 
we want to, during a simulation, add a number of molecules in a certain state, and at a later time 
remove them again. Our solution is the following: 
First, we add synthesis and degradation rules for the insulin molecule: 
  0                         -> insulin(IRD)           insulin_prod() 
  insulin                   -> 0                     insulin_deg() DeleteMolecules 
 Here the reaction rates “insulin_prod()” and “insulin_deg()” are function calls we will define below. 
We furthermore state that the produced insulin will be in the unbound state, and that the degradation 
rule matches insulin in any state. The “DeleteMolecules” keyword is necessary for our desired 
behaviour: it says that if we degrade an insulin molecule that is connected into some complex, we 
should not remove that entire complex from the system, but just the insulin molecule – possibly 
breaking the complex into subunits along the way. 
We furthermore define two parameters: 
     ins_prod_0    0 
ins_deg_0     0 
and set the seeded concentration of insulin(IRD) to 0. 
An observable 
  Molecules INSULIN   insulin 
which appears in the functions 
  insulin_prod() = ins_prod_0 * abs(Numinsulin - INSULIN) 
  insulin_deg()  = ins_deg_0  * INSULIN 
The INSULIN in these functions is the observable defined above, and Numinsulin is the desired 
insulin number, set at 1000. We take the absolute value of the difference such that the reaction rate is 
strictly positive. 
Using this functional form for the reaction rates allows us to control the production and degradation of 
insulin by controlling the values of the parameters “ins_prod_0” and “ins_deg_0”, which we can do 
(see below). By setting ins_prod_0 to a high number (compared to the other rate constants), the 
production will be active when the number of insulin molecules is smaller than Numinsulin, and when 
it reaches Numinsulin, the production will be turned off again. By setting ins_deg_0 to a high number 
the degradation of insulin will be active as long as there is insulin present in the system. 
All that is left now is writing a script that performs the simulation and changes the ins_prod_0 and 
ins_deg_0. For this we first need to generate an XML file that can be read by NFsim by ending the 
BNGL file with the following action: 
  writeXML(); 
In the current version NFSim’s bundled BioNetGen (2.2.2), this crashed since there was a parsing 
error in the synthesis rule. Using a more recent version of BioNetGen (2.2.6) solved that problem. 
The script (a so-called RNF file) contains the following commands, where “insulin.xml” is the just-
created XML file. 
-xml insulin.xml 
-v 
-o insulin_nf.gdat 
begin 
  sim 50 200 
  set ins_prod_0 100 
  update 
  sim 50 200 
  set ins_prod_0 0 
  set ins_deg_0 100 
  update 
  sim 50 200 
end 
This will simulate the system for 50 units, outputting 200 data points, set the production of insulin to 
100, simulate again, set the production of insulin to 0 and the degradation to 100, and simulate again. 
The results of the NFSim simulations, both with and without the extra phosphorylation reactions, are 
given in Figures 6B and C. 
  
Figure legends 
Figure 1: The network reconstruction process and the levels of information depth. (A) The 
conceptual network seed defines the scope and key components. The Input [I] and Output [O] in the 
network need to be identified, together with the components, here shown as three kinases (K1-K3), 
that connect the in- and output. Ideally, the pair wise connection between the components can be 
determined (dashed lines). (B) The reaction layer connects the components. In the next step, the 
network seed is refined by defining the actual reactions in the network. For this step, the type of 
reactions between the component pairs (red arrows), as well as the states they produce or consume, 
need to be identified. (C) The reaction layer lacks causal information. Here, the same information as 
in (B) is used to display the elemental states that are consumed and produced in each reaction. Note 
that the network falls apart in isolated motifs. (D) The causal layer connects the reactions and states. 
The contingencies (red edges) define how reactions (or outputs) depend on states (or inputs). Both the 
reaction and contingency layers are required to create a connected network at the level of information 
transfer. The graphs are visualised in SBGN-AF format [21]. 
Figure 2: The syntax of elemental reactions and states. (A) Elemental reactions are defined by one 
or two components and a reaction type, which are separated by underscores when written as strings. 
The Components may be specified with domain and/or residues, depending on the reaction type, 
resulting in states that are defined at the same resolution. The locus (domain and/or residue) are 
flanked by hard brackets and separated from the component by an underscore. The residue is 
additionally flanked by normal brackets. For interactions between components (here exemplified by a 
protein-protein interaction; upper), the resolution becomes elemental (i.e. indivisible and mutually 
exclusive; see table 1) at the level of domains. For covalent modifications (here exemplified by a 
phosphorylation; lower), the resolution becomes elemental at the level of residues. The elemental 
states have the same resolution as reactions. The dimerisation is indicated by a double dash “--” and 
the phosphorylation by appending “-{P}”. Elemental states of one domain or residue are mutually 
exclusive with other elemental states at the same domain or residue. (B) Contingencies are defined by 
a reaction (or output) and a combination of elemental states and inputs. Combinations of elemental 
states can be expressed as Boolean states, which make it possible to define structured complexes. In 
this example, the binding of insulin requires dimerisation of the receptor but also that insulin has not 
been bound already (as the receptor dimer only binds one insulin molecule [20]). To express this in 
rxncon, the reaction IR_[lig]_i_insulin requires the Boolean state <IR-empty>. <IR-Empty> is in turn 
defined as a complex with two IR monomers at position 0 and 1, where the first is equivalent to the IR 
in the reaction (the reactants have position 0 and 1 in the namespace of the reaction). The reaction 
defines that the IR binding insulin must be unbound (a component can only have one bond per 
domain), and the contingency defines that it must be in complex with another IR which in turn has no 
bond at the domain binding insulin. Hence, this defines an IR dimer without insulin bound. 
Figure 3: The insulin model. (A) Schematic representation of the insulin signalling pathway. 
Extracellular insulin binds the dimerised insulin receptor (IR), which autophosphorylates and then 
recruits and phosphorylates the insulin receptor substrate (IRS) and Shc, which in turn, when 
phosphorylated, binds to Grb2/SOS or the phosphoinositide-3-kinase (PI3K). The figure is adapted 
from [20]. (B) The rxncon reaction graph visualises the reaction layer of the mechanistic model. 
Major light green nodes: Components. Minor light green nodes: Domains. Minor dark blue nodes: 
Residues. Red arrows: Phosphorylations. Grey edges: (Protein-protein) interactions. The network is 
connected from the top component (insulin) to the two bottom-most components (PI3K and SOS). 
Figure 4: The reaction-contingency model. The rxncon model visualised as a regulatory graph, 
which shows elemental reactions (red nodes) and elemental states (blue nodes). The reaction edges 
(blue arrow; production, purple “tee”-arrow; consumption) define which elemental reactions produce 
or consume which elemental states. The contingency edges (green arrow; activation, red “tee”-arrow; 
inhibition (not used in this model) define which elemental states activate or inhibit which elemental 
reactions. Certain contingencies cannot be defined by individual elemental states; these are defined 
via Boolean contingencies (white triangles: AND, white diamonds: OR, white octagons: NOT). In this 
graph, we can follow the path from the most upstream reaction: (IR_[lig]_i_insulin_[IR]through the 
pathway until it reaches the two outputs: [PI3K] and [Ras]. Hence, the graph appears complete. 
Figure 5: The Boolean simulation results. (A) The initial model can activate, but not deactivate, the 
insulin signal. The heatmap shows the state evolution for each elemental reaction and state (rows) 
over time (columns). The colours indicate the state: Dark grey = true, white = false. The simulation is 
initiated with the insulin states false, the neutral states of all the other components true and all 
reactions and the outputs false. The model is simulated until the first steady state is reached (i). (B) As 
expected, the outputs remain off (B). The neutral state of insulin is set to true, and the simulation 
repeated until the next steady state is reached (ii). The pathway turns on. To set insulin to false, all 
insulin states, as well as all reactions that produce them, have to be set to false. With insulin set to 
false, the simulation is repeated until the next steady state (iii). Surprisingly, the signal does not turn 
off despite insulin being off, which also means a new steady state not seen before. Hence, the 
simulation is repeated, this time with insulin on, until the fourth steady state is reached (iv). As 
expected the outputs are on, and a closer inspection reveals that steady state four is identical to steady 
state 2 – hence, we have explored the possibilities of the model (at least using synchronous 
deterministic simulation). (C) To determine why the model failed to shut down, we inspect all the 
reactions and states that differed between steady state 1 and 3 (grouped in classes to make the list 
shorter). We see that the first entries in the list are residues that lock in the phosphorylated states. 
Closer inspection reveals seven such residues, for which we add dephosphorylation reactions (Table 
4). (D) We repeat the simulation with the updated model. The seven new reactions are placed at the 
bottom. (E) The output now responds as expected to insulin, and steady state 3 is equal to steady state 
1 – consequently we only perform three simulations. (F) Closer inspection of the problematic states 
and reactions from (C) reveals that they all return to the off state in the updated model. 
Figure 6: Simulation of the rule based model. (A) ODE simulation of the insulin response system in 
the absence of extra dephosphorylation reactions. (B) NFSim simulation of the insulin response 
system in the absence of the extra dephosphorylation reactions. The behaviour is similar to the ODE 
solution in (A), except for the stochastic noise. (C) NFSim simulation of the insulin response system 
in the presence of the seven extra dephosphorylation reactions. To obtain a signal with a decent signal 
to noise ratio, the parameters related to the dephosphorylation reactions were chosen as follows: all 
phosphatases have molecule counts of 10, and the dephosphorylation reactions have a rate constant of 
0.025. After insulin switches off, both the AKT and RAS responses switch off. The steady-state 
response is lower because it requires fully phosphorylated complexes, which are less numerous in the 
presence of dephosphorylation reactions. 
Table 1: The reaction type definition. The table defines what constitute well-formed reaction 
statements, and how these statements translate into a rule in a rule-based model via a skeleton rule. 
Each entry in these tables provides a definition for a certain type of reactions. The table gives the 
constraints that the component specifications appearing in a reaction statement have to adhere to in 
order for the statement to be well-formed. First, the “!MolType” defines which type (i.e. Protein, 
DNA, mRNA or Any) the reaction operates on. Second, the “!Resolution” specification defines the 
level of resolution (Component, Domain or Residue). For example, in the definition for a 
phosphorylation it is stated that the subject has to be a Protein specification at the Component 
resolution and the object a Protein specification at the Residue resolution. This means that 
A_p+_B_[(r)] is a valid statement, whereas A_p+_B is not since B is stated at the Component 
resolution. However, the user can also provide a reaction at a lower resolution than required. In this 
case, a generic locus name is generated to make the resolution elemental. The “!SkeletonRule” 
defines the translation of the rxncon statement into a reaction rule, which is subsequently compiled to 
BNGL. We discuss the details elsewhere [9], but highlight two key features: (1) reactions consume 
and produce elemental states that live either on molecules or bonds between molecules, (2) we allow 
for “method calls” on Specification objects that return other Specification objects (i.e. in the 
translation reaction: $y.to_protein_component_spec returns the ProteinSpecification corresponding to 
the MRnaSpecification $y). All the “standard” reactions that come out of the box in the rxncon 
framework are defined precisely in this table, and the user can add further definitions in the 
ReactionTypeDefinition sheet to be parsed together with the model. Note that new modification types 
also need to be defined in the ModificationTypeDefinition sheet. 
Table 2: The reaction list of the insulin model. The reaction layer of the insulin model is defined by 
17 elemental reactions, which fall into two classes: complexation (ppi = protein-protein interaction; i 
= (other) interaction) and covalent modification (P+ = phosphorylation, AP = autophosphorylation). 
In rxncon, autophosphoryaltion is always within a single molecule, so “autophosphorylation in trans” 
translate to a normal phosphorylation reaction. 
Table 3: The contingency list of the insulin model. The contingency layer of the insulin model is 
defined by 20 contingencies, which spread over 35 lines due to the definition of Boolean states. In this 
model definition, we only used absolute requirements (!) to define contingencies and the Boolean 
operators AND and OR to define Boolean states. 
Table 4: The dephosphorylation reactions added to the insulin model in the gap filling process.  
The model evaluation showed that the phosphorylated states need to be reversible for the network to 
be responsive to insulin in both directions. However, the identities of the phosphatase(s) are unknown, 
hence we add seven unknown phosphatases (uPPase) that may or may not be identical across two or 
more reactions. 
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4. Notes 
                                                          
1  Anaconda provides an easy way to install the most recent Python, as well as R and RStudio that 
is used for the bipartite Boolean model analysis. It can be downloaded from: 
https://www.continuum.io/downloads 
 
2  The installation process differs slightly between operating systems: 
 
Under Windows: 
- Open the console and type “pip install rxncon”.  The default installation folder will depend 
on your Python installation. With a python install though Anaconda, the rxncon folder 
appears in [user]/Anaconda3/lib/Site-packages. The files you will need to call appear in 
[user]/Anaconda3/Scripts. 
- To test the installation, navigate the console to the folder with the scripts and type “python 
rxncon2bngl.py”.  Expect a string “Usage: rxncon2bngl.py [OPTIONS] EXCEL_FILE” and 
an error message “Error: Missing argument “excel_file”. 
 
Under OS X: 
- Open the console and type “pip install rxncon”. The default installation folder will depend 
on your Python installation. With Anaconda, the rxncon folder appears in 
[user]/Anaconda3/lib/python3.6/Site-packages. The files you will need to call appear in 
[user]/Anaconda3/bin. 
- To test the installation, navigate the console to the folder with the scripts and type “python 
rxncon2bngl.py”.  Expect a string “Usage: rxncon2bngl.py [OPTIONS] EXCEL_FILE” and 
an error message “Error: Missing argument “excel_file”. 
 
Under Linux: 
- Make sure you have PIP installed. If not, use your package manager to install it. E.g., on 
debian-based systems type “sudo apt install python3-pip”. 
- Open a terminal and type “pip3 install rxncon --user”. This installs into $HOME/.local, the 
executables are in $HOME/.local/bin. 
- To get easy access to the rxncon scripts, you can update your PATH environment variable to 
include this directory: put something like “export PATH=$HOME/.local/bin:$PATH” into 
your .bashrc. 
- To test the installation, type “rxncon2bngl.py”.  Expect a string “Usage: rxncon2bngl.py 
[OPTIONS] EXCEL_FILE” and an error message “Error: Missing argument “excel_file”. 
                                                                                                                                                                                    
 
3  Elemental states are defined by the Specs (Component + Locus) and a state. There are five 
slightly different ways these states can look: 
i. Bond state (dimer): A_[domA]--B_[domB] 
ii. Bond state (intramolecular): A_[domA]--[domB] 
iii. Unbound domain: A_[domA]--0 
iv. Covalent modification: B_[res]-{mod} 
v. Unmodified residue: B_[res]-{0} 
where “A” is componentA’s name, “B” is the componentB’s name, “domA” and “domB” are 
the domain names, “res” is the residue name, and “mod” is the modification type. 
 
4  Note that elemental states can be defined without a locus. In this case, it is equivalent to an 
“OR” statement of all matching elemental states. 
 
 
5  A bidirectional reaction (“!BidirectionalVerb” = yes) is internally converted into a forward and 
a reverse reaction. These get unique names by concatenating “!UID:ReactionKey” with “+” and 
“-“. Therefore, these names must also be reserved. 
 
6 An open source R package (v 2.1.1) provided by the cran-r-project (https://cran.r-project.org/; 
18. Mussel, C., M. Hopfensitz, and H.A. Kestler, BoolNet--an R package for generation, 
reconstruction and analysis of Boolean networks. Bioinformatics, 2010. 26(10): p. 1378-80.). 
 
7  This can also be done through the Anaconda Navigator, if Anaconda is installed, in which case 
the RStudio install includes R. 
 
8  R can be installed through Anaconda, by opening the console and typing: “conda install –c r r-
essentials” 
 
9  In the console, type “R” to enter the R environment. Then type “install.packages("BoolNet")” 
and select the download server. 
 
10  To install NFSim: 
1. Make sure PERL is installed. E.g., by typing ”perl -v” in the console. If not, install PERL 
first. 
2. Download NFsim from http://michaelsneddon.net/nfsim/download/, and extract the 
content to a suitable folder. This includes a binary for Windows, Mac and Linux. 
                                                                                                                                                                                    
3. To test the installation, open the console and navigate to the NFsim folder. Type “perl 
BNGL.pl –v”. Expect  “BioNetGen version 2.2”. 
 
11 The scope of the network depends on the objective and aim of your study. Think about which 
parts of the network are important to include and what is not part of your interest. The scope 
often changes during the model building, but it is helpful to have a clear idea about the 
functions and components to be included – even if that is a moving target. 
 
12 The input and output of a pathway define the border between the detailed mechanistic model 
and the surrounding cell. Think about the input/output behaviour as the macroscopic function of 
the pathway, which the detailed molecular mechanisms should explain 19. Hlavacek, W.S. and 
J.R. Faeder, The complexity of cell signaling and the need for a new mechanics. Sci Signal, 
2009. 2(81): p. pe46.. Typical examples of inputs can be signals or cellular states, and examples 
of outputs include transcriptional activation or cellular decisions. Technically, an input will 
behave like an elemental state, i.e. it acts as an activator or inhibitor of one or more reaction(s). 
Correspondingly, the outputs will behave like reactions, i.e. they respond to a (set of) elemental 
state(s). 
 
13  This is not good practice. The quality of the model generally improves with the number of 
different sources, and we strongly recommend the use of multiple sources even for this stage 
and definitely for the mechanistic model building. However, we settle for a single paper as this 
model is for demonstration purposes only. 
 
14  The presumed connections are a good starting point to find relevant network information, as 
they can be used to narrow down literature searches. However, this is only sufficient if the 
network draft is complete, which is unlikely. It is important to keep in mind that probably other 
components and reactions between components are needed to connect the model input with the 
output. 
 
15  In rxncon, the core reaction definition only includes the component(s) that change and (for 
some reactions) a catalyst. Complex reactants are defined using contingencies. 
 
16  New reaction types are defined by adding lines to the ReactionTypeDefinition sheet. The 
different columns are described briefly in the materials section above, and in detail elsewhere 9.
 Romers, J.C. and M. Krantz, rxncon 2.0: a language for executable molecular systems 
biology. bioRxiv, 2017.. To extend the list, it is essential to make sure IDs are unique, and that 
                                                                                                                                                                                    
the molecule type and resolution is consistent with the skeleton rule. In addition, the 
modification type must be defined in the ModificationTypeDefinition sheet. It is helpful to map 
new reaction types on the existing ones. 
 
17  This entry must match one of the “!UID:ReactionKey” entries in the ReactionTypeDefinition 
sheet. 
 
18  The resolution depend on the state(s) that change: Covalent modifications live on residues and 
bonds live on domains. Catalysts and components that are synthesised or degraded are to be 
defined at the component level. 
 
19  Intramolecular reactions, such as autophosphorylation or intramolecular bond formation, are 
defined by entering the same component name in “!ComponentA:Name” and 
“!ComponentB:Name”. Note that the domains and/or residues may differ, though. 
 
20  For catalytic or transport reactions, the “active” component should be specified as Component 
A. For all reciprocal or non-directional reactions, the order is arbitrary. However, the order 
must be consistent in all entries: The software will not realise that A bound to B and B bound to 
A are the same complexes. Hence, we recommend alphabetic order in these cases. 
 
21  Domains are required for bonds. Bonds targeting the same domain in the same molecule are 
mutually exclusive; hence domain names have an impact on the model generation. If domains 
are required but not specified, they will be assigned unique names in the parsing step. 
 
22  Domains may be defined when residue information is required. In this case, the residue will 
live on the domain. This only affects partially undefined contingencies: If the contingency is 
specified with a phosphorylation at domain resolution only, this will correspond to an or 
statement phosphorylation on all sites within this domain.  
 
23  Residues are required for covalent modifications. Covalent modifications targeting the same 
residue in the same molecule are mutually exclusive; hence residue names have an impact on 
the model generation. If residues are required but not specified, they will be assigned unique 
names in the parsing step. 
 
24  We prefer using pubmed IDs but any unique identifier would be suitable for references. 
 
                                                                                                                                                                                    
25  The framework is browser based but a local server is running. All files uploaded to the 
framework will stay on your local machine, but are saved separately. 
 
26  To generate the reaction graph using the console, type: “python 
[path1]\rxncon2reactiongraph.py [path2]\[model]” where “[path1]” and “[path2]” are the paths 
to the rxncon scripts and model folder, respectively, and “[model]” is the file name including 
file extension. 
 
27  If you have already laid out an older version of the graph in Cytoscape, you can export this 
view and use it as a template for upcoming graphs. For this click ‘choose file’ and select the file 
with the layout you want before creating the graph.   
  
If you transfer the layout of an already existing graph (template graph) the graph should be 
in .xgmml format. The species information in both files will be compared with each other and if 
there are known coordinates for a certain species in the template graph these will be transferred 
to the new graph. All species which are not mentioned in the template graph will be visualised 
centred in Cytoscape. 
 
28 The rxncon2cytoscale.xlm style file can be downloaded from: https://github.com/rxncon/tools. 
 
29  There are automatic layouts provided by Cytoscape. Click on Layout in the upper Menu -> 
choose a layout -> All Nodes. This will give you a good starting point you can further proceed 
from. 
 
30  The elemental reactions and states (that are defined in the reaction layer) are needed to define 
the contingencies in the causal layer. Hence, the reaction layer is a prerequisite for the causal 
layer (see figure 1). However, in practice, the model building goes back and forth between 
reactions and contingencies. 
 
31 Contextual information is not always easy to find, as it takes dedicated experiments to identify 
all the requirements. Depending on the number of modification sites and interaction partners, 
these experiments can be time and resource demanding. Consequently, we expect many 
important contingencies to remain unknown. 
 
                                                                                                                                                                                    
32  This can be the existence of the component itself. However, components are typically regulated 
in information transfer networks, meaning that the state of the component determines its 
activity. 
 
33 Keep in mind that for a functional pathway, the active forms of the components need to be 
reversed when the signal is not present anymore. For this, the reverse reactions will be needed 
to reset the components. These are implicit for interaction reactions, but not for covalent 
modification or synthesis/degradation reactions. 
 
34  There are six contingency symbols. Two absolute: ! = required; x = inhibitory. Two 
quantitative K+ = stimulation, K- = inhibition. Two with no effect: 0 = known to have no 
effect, ? = no known effect. The last two are equivalent for the interpretation of the model. 
 
35  Boolean contingencies can be defined in the same format for convenience. If so, the target is a 
Boolean state (defined by name within pointy brackets < >), the modifier elemental states, 
Boolean states, or inputs; and the contingency symbol is the type of Booelan: AND, OR, NOT. 
Note that a single Boolean state can only take one Boolean expression: Use nested Booleans to 
create mixed statements. 
 
36  Input and outputs defined the borders between the mechanistic rxncon model and the 
surrounding. Note that they can also be used as borders to internal processes that are not well 
known. By assigning the same name to an input and an output, these are made equivalent, 
essentially forming a feedback into the pathway. The effect of this varies with modelling 
formalism. 
 
37  The components listed in the reaction always have indices 0 (component A) and 1 (component 
B). It is imperative that all indices in the contingencies are consistent with these, and with each 
other. Note that each Boolean has its own namespace, and equivalences must be declared when 
a Boolean is used. For examples, see the contingency list in the insulin example (Table 3). 
 
38  Equivalences must be defined in structured complexes or when the component name is an 
ambiguous identifier (e.g. in homodimers or reactions between two copies of the same 
component). For examples, see the contingency list of the insulin example (Table 3). 
 
                                                                                                                                                                                    
39  The graph can be created from the command line: “python [path1]\rxncon2regulatorygraph.py 
[path2]\[model]” from the console. In the GUI, the “regulatory graph” button should be 
selected. For all other purposes, see the reaction graph creation. 
 
40  The regulatory graph is a simplified view of the regulatory structure of the rxncon model. 
Alternatively, the full set of states and reactions can be visualised with the species-reaction 
graph. The graph can be created from the command line: “python [path1]\rxncon2srgraph.py 
[path2]\[model]” from the console. In the GUI, the “species-reaction graph” button should be 
selected. For all other purposes, see the reaction graph creation. 
 
41  The visualisation process is the same as for the reaction graph, except that the style chosen 
should be rxncon_regulatorygraph. 
 
42 The QlM you created can be evaluated using a Boolean model. In this modelling approach, you 
assume that each node in your model can have only two states: Either True/1/on or False/0/off. 
Each node is defined by a specific update function, describing the dependency on other nodes 
of the system. At each time step t the rule for a certain component is evaluated by substituting 
the components within a rule by their states. The result will be the state of this component at 
t+1. Here, we create update rules for state and reactions, rather than components (the typical 
approach). This has two nice advantages: First, we can derive a unique model (with defined 
truth tables) from each rxncon network. Second, we can distinguish different active states. 
 
43 Type: “python [path1]\rxncon2boolnet.py [path2]\[model]” where “[path1]” and “[path2]” are 
the paths to the rxncon scripts and model folder, respectively, and “[model]” is the file name 
including file extension. 
 
44 The different options for the Boolean model generation are listed by calling the program with 
the “--help" option. They can be selected by calling the command line program with certain 
flags. Currently, options exit to: 
• control smoothing the availability of source states in time, 
• express knockouts or overexpressions, 
• choose whether to interpret positive influences / negative influences as strict requirements / 
strict inhibitions or to ignore them, and 
• select an output filename. 
 
45 The same options as above are available. 
                                                                                                                                                                                    
 
46 Typically, these models are too large for an exhaustive scan of initial configurations, as the 
number of possible starting states is 2n, where n equals the number of nodes. Instead, we start 
from a generic start position where all components without states are on, all neutral states are 
on, and all other nodes are off. See 12. Thieme, S., et al., Bipartite Boolean modelling - a 
method for mechanistic simulation and validation of large-scale signal transduction networks. 
bioRxiv, 2017. for details. From this starting point, we typically perform a simulation to let the 
system find its own natural initial state, before starting to change the input configuration. 
   
47 Here, we show how to simulate and plot a network in R-studio 
(https://www.rstudio.com/products/rstudio/download2/) using the BoolNetSim.R script that can 
be downloaded from GitHub (https://github.com/rxncon/tools). The R-script contains some 
comments for your convenience. You can also run the commands line by line.  Change the R-
script to adapt it to your needs. 
 
48 Alternatively, define the path to the model files when setting the model prefix (below). 
 
49 Where [model] is the file name of the rxncon model without file extension. This should also 
include a path if your file is located in a different directory than the R-script. 
 
 On some machines, the script may not open correctly. If so, simply copy/paste the text from the 
script into R-Studio, and define the file prefix with path to the model file. 
 
 
50  The script executes a second simulation from the first attractor to test whether it is a point or 
cyclic attractor. In the first case, the second simulation results consist of two identical columns 
(starting point, and final attractor). In the second case, the simulation results consist of more 
than two columns that change. 
 
51  This is either the point attractor or a single state in a cyclic attractor, depending on the model. 
 
52  The key to the symbols can be found in the “[model]_symbols” file. 
 
53  As we use deterministic updates, we have seen all states we can reach from these input 
configurations. 
 
                                                                                                                                                                                    
54  It is important to check this in both directions. It is easy to create a model that only responds in 
one direction, or only once. Therefore, the input needs to be varied until the model returns to a 
previous steady state – and the output should still be responsive. As can be seen in the insulin 
example, this is not necessarily the case even when the regulatory graph appears connected and 
the output responds the first time. 
 
55  The heatmap and the regulatory graph are powerful tools to help this search. The (sorted) 
heatmap can be used to track down the first reactions / states that do not change as expected, 
and the regulatory graph summarise the complete regulatory information at a graphical level. 
 
57  If one type of error is detected (e.g. missing phosphorylation), they are likely to appear 
elsewhere too. Hence, it makes sense to visually inspect the regulatory graph for other possible 
sources of similar problems before repeating the complete cycle. In one case, we needed to add 
fifty hypothetical dephosphorylation reactions (15. Flottmann, M., et al., Reaction-contingency 
based bipartite Boolean modelling. BMC Syst Biol, 2013. 7: p. 58.). 
 
58  In some cases, the default assumptions in the bBM generation may be inappropriate. If so, this 
could prevent the model from passing the validation step. If this appears to be the case, adapt 
the bBM manual to the appropriate update rules. 
 
59   To call the script from the command line, type “python [path1]\rxncon2bngl.py 
[path2]\[model]” with the same paths as for Boolean model export above. 
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Table 2
!ComponentA:
Name
!ComponentA:
Domain
!ComponentA:
Residue !Reac on
!ComponentB:
Name
!ComponentB:
Domain
!ComponentB:
Residue
IR IRBD ppi IR IRBD
IR lig i insulin
IR p+ IR TK Y1158
IR p+ IR TK Y1162
IR p+ IR TK Y1163
IR ap+ IR JM Y972
IR JM ppi IRS PTB
IRS i Phospholipids
IR p+ IRS bd Y
Grb2 ppi SOS
Grb2 SH2 ppi IRS bd
IR JM ppi Shc PTB
IR p+ Shc bd2 YY239
IR p+ Shc bd1 Y317
Grb2 SH2 ppi Shc bd2
Grb2 SH2 ppi Shc bd1
IRS bd ppi PI3K SH2
Table 3
!Target !Con ngency !Modifier
IR_[lig]_i_insulin ! <IR‐empty>#IR@0=IR@0
<IR‐empty> AND IR@0‐‐IR@1
<IR‐empty> AND IR@1_[lig]‐‐0
IR_p+_IR_[TK(Y1158)] ! <IR‐Ins>#IR@0=IR@0#IR@1=IR@1
<IR‐Ins> AND IR@0‐‐IR@1
<IR‐Ins> AND <IR01‐Ins>#IR@0=IR@0#IR@1=IR@1
<IR01‐Ins> OR IR@0_[lig]‐‐insulin@2
<IR01‐Ins> OR IR@1_[lig]‐‐insulin@3
IR_p+_IR_[TK(Y1162)] ! <IR‐Ins>#IR@0=IR@0#IR@1=IR@1
IR_p+_IR_[TK(Y1163)] ! <IR‐Ins>#IR@0=IR@0#IR@1=IR@1
IR_ap+_IR_[JM(Y972)] ! <IRac ve>#IR@0=IR@0
<IRac ve> AND <IR‐phos>#IR@0=IR@0
<IRac ve> AND <IR‐Ins>#IR@0=IR@0
<IR‐phos> AND IR@0_[TK(Y1158)]‐{P}
<IR‐phos> AND IR@0_[TK(Y1162)]‐{P}
<IR‐phos> AND IR@0_[TK(Y1163)]‐{P}
IR_[JM]_ppi_IRS_[PTB] ! IR_[JM(Y972)]‐{P}
IR_[JM]_ppi_IRS_[PTB] ! IRS‐‐Phospholipids
IR_p+_IRS_[bd(Y)] ! IR_[JM]‐‐IRS_[PTB]
IR_p+_IRS_[bd(Y)] ! <IRac ve>#IR@0=IR@0
Grb2_[SH2]_ppi_IRS_[bd] ! IRS_[bd(Y)]‐{P}
IR_[JM]_ppi_Shc_[PTB] ! IR_[JM(Y972)]‐{P}
IR_p+_Shc_[bd2(YY239)] ! IR_[JM]‐‐Shc_[PTB]
IR_p+_Shc_[bd2(YY239)] ! <IRac ve>#IR@0=IR@0
IR_p+_Shc_[bd1(Y317)] ! IR_[JM]‐‐Shc_[PTB]
IR_p+_Shc_[bd1(Y317)] ! <IRac ve>#IR@0=IR@0
Grb2_[SH2]_ppi_Shc_[bd2] ! Shc_[bd2(YY239)]‐{P}
Grb2_[SH2]_ppi_Shc_[bd1] ! Shc_[bd1(Y317)]‐{P}
IRS_[bd]_ppi_PI3K_[SH2] ! IRS_[bd(Y)]‐{P}
<Grb2‐SOS> AND Grb2‐‐SOS
<Grb2‐SOS> AND <GS>
<GS> OR Grb2_[SH2]‐‐Shc_[bd2]
<GS> OR Grb2_[SH2]‐‐IRS_[bd]
[RAS] ! <Grb2‐SOS>
[PI3K] ! IRS_[bd]‐‐PI3K_[SH2]
Table 4
!ComponentA:
Name
!ComponentA:
Domain
!ComponentA:
Residue !Reac on
!ComponentB:
Name
!ComponentB:
Domain
!ComponentB:
Residue
uPPase1 p‐ IR TK Y1158
uPPase2 p‐ IR TK Y1162
uPPase3 p‐ IR TK Y1163
uPPase4 p‐ IR JM Y972
uPPase5 p‐ IRS bd Y
uPPase6 p‐ Shc bd2 YY239
uPPase7 p‐ Shc bd1 Y317
